AMAgnes Moses

Agnes Moses

*This is an algorithmically generated author record based on publicly available information.

Agnes Moses has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk factors for common cancers among patients at Kamuzu Central Hospital in Lilongwe, Malawi: A retrospective cohort study

    by Agnes Moses, Albert Mwafongo, Maria Chikasema, Laureen Kafantenganji, Christopher Stanely, Emma Chimzukira, Coxcilly Kampani, Robert Krysiak, Satish Gopal, Nora E. Rosenberg, et al.

    Risk factors for common cancers among patients at Kamuzu Central Hospital in Lilongwe, Malawi: A retrospective cohort study


  • Open Access

    Leveraging HIV Research and Implementation for Cancer and Noncommunicable Diseases in Malawi

    by Mwapatsa Mipando, Nyengo Mkandawire, Jones Masiye, Emily Wroe, Luckson Dullie, Ron Mataya, Adamson Muula, Victor Mwapatsa, Charles Dzamalala, Leo Masamba, et al.

    33 Background: Enabled by collaboration and political stability, Malawi is a global leader for HIV research and implementation. We undertook this work to identify ways to leverage successes in HIV treatment and research for cancer and noncommunicable diseases (NCDs). Methods: Over more than two decades, investment from the National Institutes of Health (NIH) and other funders has allowed Malawi participation in international HIV networks. As these sought to address HIV-positive cancer, investment occurred to increase pathology, improve cancer registration, scale up cervical cancer screening, and improve nursing and pharmacy skills for chemotherapy administration. This allowed Malawi to participate in multinational clinical trials for HIV-positive Kaposi sarcoma treatment and cervical cancer prevention. Building on this, Malawi was one of six countries in 2014 to receive an NIH U54 consortium award for HIV-positive malignancies and was one of six countries added to the National Cancer Institute (NCI) AIDS Malignancy Consortium. In 2016, expanding beyond HIV-positive cancer, Malawi was one of three countries invited to join a new NCI–International Agency for Research on Cancer esophageal cancer consortium, one of five recipients of a new NCI Burkitt lymphoma award, and one of six recipients of a new NCI P20 grant for a regional center of research excellence for NCDs. Malawi is also one of 11 countries to convene a Lancet noncommunicable diseases and injury poverty commission for NCDs and injury. Finally, partners have improved surveillance and treatment for hypertension, diabetes, injury, and sickle cell anemia, in part, through a national Knowledge Translation Platform for HIV-NCD integration. With this support and funding, career development opportunities are embedded for Malawian NCD researchers. Results: Building on successes in HIV treatment and research, Malawi has become a global leader for cancer and NCD research and implementation. Conclusion: Continue developing a multilateral national platform for NCD research and implementation that is globally impactful and can lead to measurable outputs for individual cancer and NCD focus areas. Funding: National Institutes of Health. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST No COIs from the authors.

  • Open Access

    Factors associated with cancer pathogenesis among patients attending oncology clinic at Kamuzu Central Hospital in Malawi

    by Agnes Moses, Elizabeth Bigger, Lindsey Wolf, Mike Owino, Albert Mwafongo, Maria Chikasema, Loreen Chiwoko, Mina Hosseinipour, Carol Shores